DEERFIELD MANAGEMENT COMPANY, L.P. historic quarter change: USA Options, Sold out
In put and call options, at their filed underlying value (listed in the US), over 23 quarters from 2013-06-30 to 2026-06-30, DEERFIELD MANAGEMENT COMPANY, L.P. opened 28 positions, added to 4, reduced 5 and sold out of 36.
- Q1 2026: Stock MRNA; Country of operation United States; Class COM · Put; Shares before 1,000,000.
- Q2 2025: Stock ESTA; Country of operation —; Class COM · Put; Shares before 500,000.
- Q1 2016: Stock GILD; Country of operation United States; Class COM · Call; Shares before 532,000.
- Q3 2015: Stock EXEL; Country of operation United States; Class COM · Put; Shares before 4,000,000.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1009258), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 1999-03-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q1 2026 | MRNA
MODERNA INC | United States | COM · Put | 1,000,000 | 0 | -1,000,000 | $29,490,000 | $0 | -$29,490,000 | 2026-05-15 |
|---|
| Q2 2025 | ESTA
ESTABLISHMENT LABS HLDGS INC | | COM · Put | 500,000 | 0 | -500,000 | $20,402,500 | $0 | -$20,402,500 | 2025-08-14 |
|---|
| Q1 2016 | GILD
GILEAD SCIENCES INC | United States | COM · Call | 532,000 | 0 | -532,000 | $53,833,000 | $0 | -$53,833,000 | 2016-05-16 |
|---|
| Q3 2015 | EXEL
EXELIXIS INC | United States | COM · Put | 4,000,000 | 0 | -4,000,000 | $15,040,000 | $0 | -$15,040,000 | 2015-11-16 |
|---|
| Q2 2015 | GILD
GILEAD SCIENCES INC | United States | COM · Put | 200,000 | 0 | -200,000 | $19,626,000 | $0 | -$19,626,000 | 2015-08-14 |
|---|
| Q2 2015 | IMMUNOMEDICS INC
CUSIP 452907108 | | COM · Call | 500,000 | 0 | -500,000 | $1,915,000 | $0 | -$1,915,000 | 2015-08-14 |
|---|
| Q1 2015 | ALLERGAN INC
CUSIP 018490102 | | COM · Call | 200,000 | 0 | -200,000 | $42,518,000 | $0 | -$42,518,000 | 2015-05-15 |
|---|
| Q1 2015 | HUM
HUMANA INC | United States | COM · Call | 280,000 | 0 | -280,000 | $40,216,000 | $0 | -$40,216,000 | 2015-05-15 |
|---|
| Q1 2015 | EXEL
EXELIXIS INC | United States | COM · Call | 1,000,000 | 0 | -1,000,000 | $1,440,000 | $0 | -$1,440,000 | 2015-05-15 |
|---|
| Q4 2014 | HCA
HCA HOLDINGS INC | United States | COM · Put | 750,000 | 0 | -750,000 | $52,890,000 | $0 | -$52,890,000 | 2015-02-17 |
|---|
| Q4 2014 | THC
TENET HEALTHCARE CORP | United States | COM NEW · Put | 750,000 | 0 | -750,000 | $44,543,000 | $0 | -$44,543,000 | 2015-02-17 |
|---|
| Q4 2014 | CIGNA CORPORATION
CUSIP 125509109 | | COM · Put | 375,000 | 0 | -375,000 | $34,009,000 | $0 | -$34,009,000 | 2015-02-17 |
|---|
| Q4 2014 | AETNA INC NEW
CUSIP 00817Y108 | | COM · Put | 375,000 | 0 | -375,000 | $30,375,000 | $0 | -$30,375,000 | 2015-02-17 |
|---|
| Q4 2014 | MALLINCKRODT PUB LTD CO
CUSIP G5785G107 | | SHS · Call | 250,000 | 0 | -250,000 | $22,538,000 | $0 | -$22,538,000 | 2015-02-17 |
|---|
| Q4 2014 | INTERCEPT PHARMACEUTICALS IN
CUSIP 45845P108 | United States | COM · Call | 50,000 | 0 | -50,000 | $11,835,000 | $0 | -$11,835,000 | 2015-02-17 |
|---|
| Q4 2014 | KERYX BIOPHARMACEUTICALS INC
CUSIP 492515101 | | COM · Put | 700,000 | 0 | -700,000 | $9,625,000 | $0 | -$9,625,000 | 2015-02-17 |
|---|
| Q3 2014 | QUESTCOR PHARMACEUTICALS INC
CUSIP 74835Y101 | | COM · Call | 250,000 | 0 | -250,000 | $23,123,000 | $0 | -$23,123,000 | 2014-11-14 |
|---|
| Q3 2014 | ZTS
ZOETIS INC | United States | CL A · Call | 500,000 | 0 | -500,000 | $16,135,000 | $0 | -$16,135,000 | 2014-11-14 |
|---|
| Q3 2014 | INTERMUNE INC
CUSIP 45884X103 | | COM · Call | 73,500 | 0 | -73,500 | $3,245,000 | $0 | -$3,245,000 | 2014-11-14 |
|---|
| Q2 2014 | AUXILIUM PHARMACEUTICALS INC
CUSIP 05334D107 | | COM · Put | 250,000 | 0 | -250,000 | $6,795,000 | $0 | -$6,795,000 | 2014-08-14 |
|---|
| Q2 2014 | XOMA CORP DEL
CUSIP 98419J107 | | COM · Call | 1,000,000 | 0 | -1,000,000 | $5,210,000 | $0 | -$5,210,000 | 2014-08-14 |
|---|
| Q2 2014 | MANNKIND CORP
CUSIP 56400P201 | | COM · Put | 1,000,000 | 0 | -1,000,000 | $4,020,000 | $0 | -$4,020,000 | 2014-08-14 |
|---|
| Q1 2014 | CUBIST PHARMACEUTICALS INC
CUSIP 229678107 | | COM · Call | 1,000,000 | 0 | -1,000,000 | $68,870,000 | $0 | -$68,870,000 | 2014-05-15 |
|---|
| Q1 2014 | AIR METHODS CORP
CUSIP 009128307 | | COM PAR $.06 · Call | 125,000 | 0 | -125,000 | $7,283,000 | $0 | -$7,283,000 | 2014-05-15 |
|---|
| Q1 2014 | MYLAN INC
CUSIP 628530107 | | COM · Call | 150,000 | 0 | -150,000 | $6,510,000 | $0 | -$6,510,000 | 2014-05-15 |
|---|
| Q1 2014 | INFIQ
INFINITY PHARMACEUTICALS INC | United States | COM · Call | 200,000 | 0 | -200,000 | $2,762,000 | $0 | -$2,762,000 | 2014-05-15 |
|---|
| Q1 2014 | SUNESIS PHARMACEUTICALS INC
CUSIP 867328601 | | COM NEW · Call | 250,000 | 0 | -250,000 | $1,185,000 | $0 | -$1,185,000 | 2014-05-15 |
|---|
| Q4 2013 | ALLERGAN INC
CUSIP 018490102 | | COM · Call | 300,000 | 0 | -300,000 | $27,135,000 | $0 | -$27,135,000 | 2014-02-14 |
|---|
| Q4 2013 | EW
EDWARDS LIFESCIENCES CORP | United States | COM · Call | 200,000 | 0 | -200,000 | $13,926,000 | $0 | -$13,926,000 | 2014-02-14 |
|---|
| Q4 2013 | SRPT
SAREPTA THERAPEUTICS INC | United States | COM · Put | 100,000 | 0 | -100,000 | $4,723,000 | $0 | -$4,723,000 | 2014-02-14 |
|---|
| Q4 2013 | FOREST LABS INC
CUSIP 345838106 | | COM · Call | 100,000 | 0 | -100,000 | $4,279,000 | $0 | -$4,279,000 | 2014-02-14 |
|---|
| Q4 2013 | DENDREON CORP
CUSIP 24823Q107 | | COM · Put | 700,000 | 0 | -700,000 | $2,051,000 | $0 | -$2,051,000 | 2014-02-14 |
|---|
| Q4 2013 | IRWD
IRONWOOD PHARMACEUTICALS INC | United States | COM CL A · Put | 100,000 | 0 | -100,000 | $1,184,000 | $0 | -$1,184,000 | 2014-02-14 |
|---|
| Q4 2013 | GTX INC DEL
CUSIP 40052B108 | | COM · Call | 500,000 | 0 | -500,000 | $1,013,000 | $0 | -$1,013,000 | 2014-02-14 |
|---|
| Q3 2013 | CATAMARAN CORP
CUSIP 148887102 | | COM · Call | 550,000 | 0 | -550,000 | $26,818,000 | $0 | -$26,818,000 | 2013-11-14 |
|---|
| Q3 2013 | SEATTLE GENETICS INC
CUSIP 812578102 | | COM · Put | 300,000 | 0 | -300,000 | $9,438,000 | $0 | -$9,438,000 | 2013-11-14 |
|---|